ethylenediamine has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavallaro, G; Craparo, EF; Fiorica, C; Giammona, G; Porsio, B; Triolo, D | 1 |
1 other study(ies) available for ethylenediamine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate.
Topics: Anti-Inflammatory Agents; Antioxidants; Beclomethasone; Biocompatible Materials; Bronchi; Cell Survival; Drug Carriers; Drug Delivery Systems; Epithelial Cells; Ethanol; Ethylenediamines; Humans; Lung; Micelles; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Particle Size; Peptides; Surface Properties; Thioctic Acid | 2017 |